نتائج البحث - "Claire F, Verschraegen"

1

Academic Journal

Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications

المصدر: BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)

مصطلحات موضوعية: Microbiome, Immune checkpoint inhibitors, Antibiotics, Corticosteroids, Cancer, Immunotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s12885-020-06882-6; https://doaj.org/toc/1471-2407

URL الوصول: https://doaj.org/article/a2ea93cf4e3c437189a96df81b027495

View record in DOAJ

Full Text Finder

2

Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

المؤلفون: Jason J. Luke, Sarina A. Piha-Paul, Theresa Medina, Claire F. Verschraegen, Mary Varterasian, Aoife M. Brennan, Richard J. Riese, Anna Sokolovska, James Strauss, David L. Hava, Filip Janku

المصدر: Clinical Cancer Research. :OF1-OF10

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::93fa34e9a81e3f449d70ad34670bf3bd
https://doi.org/10.1158/1078-0432.ccr-23-0118

View record in OpenAIRE

3

Impact of the Immediate Release of Clinical Information Rules on Health Care Delivery to Patients With Cancer

المؤلفون: P. Abena Anyidoho, Claire F. Verschraegen, Merry Jennifer Markham, Steven Alberts, John Sweetenham, Kendra Cameron, Taher Abu Hejleh

المصدر: JCO Oncology Practice. 19:e706-e713

مصطلحات موضوعية: Oncology, Oncology (nursing), Health Policy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::10f846c226f79f93854357064a68535a
https://doi.org/10.1200/op.22.00712

View record in OpenAIRE

4

Academic Journal

Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study

المؤلفون: James L Gulley, Jaafar Bennouna, Guy Jerusalem, Janice Mehnert, Matthew Taylor, Karen Kelly, David Spigel, Marcis Bajars, Claire F Verschraegen, Edward F McClay, Nicholas Iannotti, Charles H Redfern, Franklin L Chen, John C Morris, Ding Wang, Hans Juergen Grote, Dongli Zhou, Neru Munshi

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://jitc.bmj.com/content/8/2/e001064.full; https://doaj.org/toc/2051-1426

URL الوصول: https://doaj.org/article/e6b6f8200ed4438aa9844cca535c6384

View record in DOAJ

Full Text Finder

5

A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

المصدر: Clinical Cancer Research. 29:731-741

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::393aa96c0a842a0584563af1293f4140
https://doi.org/10.1158/1078-0432.ccr-22-1552

View record in OpenAIRE

6

Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1

المصدر: Journal of Clinical Oncology. 40:1291-1300

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d95353bef9451bc8ef7cc9448c5326
https://doi.org/10.1200/jco.20.03452

View record in OpenAIRE

7

Supplementary Figure S3 from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

المؤلفون: Filip Janku, David L. Hava, James Strauss, Anna Sokolovska, Richard J. Riese, Aoife M. Brennan, Mary Varterasian, Claire F. Verschraegen, Theresa Medina, Sarina A. Piha-Paul, Jason J. Luke

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5708eb8d24c2eedd709b0743faf5dc13
https://doi.org/10.1158/1078-0432.23183903

View record in OpenAIRE

8

Supplementary Table S2 from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

المؤلفون: Filip Janku, David L. Hava, James Strauss, Anna Sokolovska, Richard J. Riese, Aoife M. Brennan, Mary Varterasian, Claire F. Verschraegen, Theresa Medina, Sarina A. Piha-Paul, Jason J. Luke

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e63cd59e34598ddc6dd5f2bdc764106
https://doi.org/10.1158/1078-0432.23183879

View record in OpenAIRE

9

Data from Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies

المؤلفون: Filip Janku, David L. Hava, James Strauss, Anna Sokolovska, Richard J. Riese, Aoife M. Brennan, Mary Varterasian, Claire F. Verschraegen, Theresa Medina, Sarina A. Piha-Paul, Jason J. Luke

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29b62888fa04e40e6c1a5fc9b6706345
https://doi.org/10.1158/1078-0432.c.6664583

View record in OpenAIRE

10

Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumors

المؤلفون: Apostolia Maria Tsimberidou, Claire F. Verschraegen, Robert Wesolowski, Chi-Sheng Shia, Pei Hsu, Tillman E. Pearce

المصدر: British Journal of Cancer.

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::26c54bd572e528c12b3f3a9264dac271
https://doi.org/10.1038/s41416-023-02280-4

View record in OpenAIRE

11

Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6043468b270edb3fbf1f89d46a600ea4
https://doi.org/10.1158/1078-0432.22490087.v1

View record in OpenAIRE

12

Supplementary Figure 3 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ae9fba1319887da8e06b3ab9a2fecb
https://doi.org/10.1158/1078-0432.22490081

View record in OpenAIRE

13

Supplementary Figure 5 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc3d0270cb96bd40ce9fede6834d0ff8
https://doi.org/10.1158/1078-0432.22490072

View record in OpenAIRE

14

Supplementary Figure 4 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ffcb961120a4390347202b59f302d8c
https://doi.org/10.1158/1078-0432.22490078.v1

View record in OpenAIRE

15

Supplementary Figure 2 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::586d7df8fbb3e5cdf2e32d9119ec79dd
https://doi.org/10.1158/1078-0432.22490084.v1

View record in OpenAIRE

16

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07edc4a3f58199667ad4a8978ad57750
https://doi.org/10.1158/1078-0432.c.6533090.v1

View record in OpenAIRE

17

Supplementary Tables 1-5 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03655d384b2380026652166b09ebe624
https://doi.org/10.1158/1078-0432.22490069.v1

View record in OpenAIRE

18

Cervical Cancer

المؤلفون: Amritjot Kaur, Claire F. Verschraegen, Harmeet Kaur

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5899992987aba33aa215b4aa51d5dfba
https://doi.org/10.1016/b978-0-323-69538-1.00026-4

View record in OpenAIRE

19

Contributors

المؤلفون: Eddie K. Abdalla, Jitesh Ahuja, Felipe Aluja-Jaramillo, Rodabe N. Amaria, Behrang Amini, Anca Avram, Rony Avritscher, Isabelle Bedrosian, Sonia L. Betancourt-Cuellar, Priya R. Bhosale, Andrew J. Bishop, Yulia Bronstein, Constantine M. Burgan, Hop S. Tran Cao, Sudpreeda Chainitikun, Joe Y. Chang, Lisly J.Chery, Hubert H. Chuang, Aaron Coleman, Colleen M. Costelloe, Prajnan Das, Reordan DeJesus, Catherine Devine, Patricia J. Eifel, Jeremy J. Erasmus, Silvana C.Faria, Jason B. Fleming, Samuel J. Galgano, Dhakshinamoorthy Ganeshan, Naveen Garg, Patrick B. Garvey, Gregory Gladish, Chunxiao Guo, Fernando R. Gutiérrez, Daniel M. Halperin, Abdelrahman K. Hanafy, Karen Hoffman, Wayne L. Hofstetter, Wen-Jen Hwu, Juan J. Ibarra Rovira, Mohannad Ibrahim, Naruhiko Ikoma, Revathy B. Iyer, Sanaz Javadi, Milind Javle, Corey T. Jensen, Eric Jonasch, Aparna Kamat, Ashish Kamat, Avinash R. Kambadakone, Gregory P. Kaufman, Amritjot Kaur, Harmeet Kaur, Brinda Rao Korivi, Rajendra Kumar, Vikas Kundra, Marcelo F. Kuperman Benveniste, Ott Le, Jeffrey H. Lee, Huang LePetross, Patrick P. Lin, Joseph A. Ludwig, Homer A. Macapinlac, John E. Madewell, Paul Mansfield, Leonardo P. Marcal, Edith M. Marom, Tara Massini, Aurelio Matamoros, Mary Frances McAleer, Reza J. Mehran, Christine Menias, Ajaykumar C. Morani, Van K. Morris, Stacy L. Moulder-Thompson, Bilal Mujtaba, Suresh K. Mukherji, Sameh Nassar, Quynh-Nhu Nguyen, Yoshifumi Noda, Amir Onn, Michael J. Overman, Lance C. Pagliaro, Diana P. Palacio, Anushri Parakh, Hemant A. Parmar, Shreyaskumar Patel, Madhavi Patnana, Alexandria Phan, Halyna Pokhylevych, Kristin K. Porter, Gaiane M. Rauch, Bharat Raval, Miguel Rodriguez-Bigas, Eric M. Rohren, Christina L. Roland, Jeremy Ross, Bradley S. Sabloff, Tara Sagebiel, Dushant V. Sahani, Kathleen M. Schmeler, Girish Shroff, Arlene O Siefker-Radtke, Elainea N. Smith, R. Jason Stafford, David J. Stewart, Chad D. Strange, Stephen G. Swisher, Ahmed Taher, Cher Heng Tan, Mylene T. Truong, Naoto T. Ueno, Gauri R. Varadhachary, Aradhana M. Venkatesan, Claire F. Verschraegen, Raghunandan Vikram, Sarah J.Vinnicombe, Mayur K. Virarkar, Chitra Viswanathan, Jason R. Westin, Wendy A. Woodward, T. Kuan Yu

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::28a5c8227639b2784debc675d001af69
https://doi.org/10.1016/b978-0-323-69538-1.00047-1

View record in OpenAIRE

20

Metastatic Spiradenocarcinoma Managed With PD-1 Inhibition

المؤلفون: Jeffrey J, Wargo, David R, Carr, Jose A, Plaza, Claire F, Verschraegen

المصدر: Journal of the National Comprehensive Cancer Network. 20:318-320

مصطلحات موضوعية: Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b39d32256a9a0efc5262f9fa37f7485c
https://doi.org/10.6004/jnccn.2021.7119

View record in OpenAIRE

تنقيح النتائج